Clinical Genomics Lund was established in 2016 as a joint strategic initiative between the Medical Faculty at Lund University and the Division of Laboratory Medicine, Medical Services, Region Skåne. The unit encompasses two centers, Center for Translational Genomics (CTG) and Center for Molecular Diagnostics (CMD) that are fully aligned and operate in tight synergy, but with separate responsible bodies and budgets (Lund University and Region Skåne, respectively). Clinical Genomics Lund aims to provide state-of-the-art next generation sequencing (NGS-) based services to strong and high-profile translational research projects and to implement new NGS-based tests for clinical diagnostics within the health-care system aiming at broader national coverage and consensus.
Clinical Genomics Lund offers expertise and service in NGS-based technologies for investigators at Lund University and Region Skåne in projects with a strong translational edge or aiming at clinical implementation of new diagnostics assays.
Clinical Genomics Lund also constitutes a physical node at which knowhow, services, education and outreach activities by the national platform Diagnostics Development will take place. Clinical Genomics Lund will also offer national services within specific high-profile areas of the unit.
Our services include:
Genome-wide and targeted DNA and RNA sequencing. Method development for variant detection, fusion gene detection, and structural variation detection for translational research projects and for diagnostic purposes.